287 related articles for article (PubMed ID: 21301797)
21. Aberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomas.
Han S; Polizzano C; Nielsen GP; Hornicek FJ; Rosenberg AE; Ramesh V
Clin Cancer Res; 2009 Mar; 15(6):1940-6. PubMed ID: 19276265
[TBL] [Abstract][Full Text] [Related]
22. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output.
Dibble CC; Manning BD
Nat Cell Biol; 2013 Jun; 15(6):555-64. PubMed ID: 23728461
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
24. mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse.
Neasta J; Barak S; Hamida SB; Ron D
J Neurochem; 2014 Jul; 130(2):172-84. PubMed ID: 24666346
[TBL] [Abstract][Full Text] [Related]
25. Mammalian target of rapamycin and the kidney. I. The signaling pathway.
Lieberthal W; Levine JS
Am J Physiol Renal Physiol; 2012 Jul; 303(1):F1-10. PubMed ID: 22419691
[TBL] [Abstract][Full Text] [Related]
26. New Insights Into the Role of mTOR Signaling in the Cardiovascular System.
Sciarretta S; Forte M; Frati G; Sadoshima J
Circ Res; 2018 Feb; 122(3):489-505. PubMed ID: 29420210
[TBL] [Abstract][Full Text] [Related]
27. Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation.
Foster KG; Acosta-Jaquez HA; Romeo Y; Ekim B; Soliman GA; Carriere A; Roux PP; Ballif BA; Fingar DC
J Biol Chem; 2010 Jan; 285(1):80-94. PubMed ID: 19864431
[TBL] [Abstract][Full Text] [Related]
28. Amino Acid Transporters Are a Vital Focal Point in the Control of mTORC1 Signaling and Cancer.
Cormerais Y; Vučetić M; Parks SK; Pouyssegur J
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375025
[TBL] [Abstract][Full Text] [Related]
29. ERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signaling.
Winter JN; Jefferson LS; Kimball SR
Am J Physiol Cell Physiol; 2011 May; 300(5):C1172-80. PubMed ID: 21289294
[TBL] [Abstract][Full Text] [Related]
30. Mammalian target of rapamycin signaling in cardiac physiology and disease.
Sciarretta S; Volpe M; Sadoshima J
Circ Res; 2014 Jan; 114(3):549-64. PubMed ID: 24481845
[TBL] [Abstract][Full Text] [Related]
31. Ubiquilin-mediated Small Molecule Inhibition of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling.
Coffey RT; Shi Y; Long MJ; Marr MT; Hedstrom L
J Biol Chem; 2016 Mar; 291(10):5221-33. PubMed ID: 26740621
[TBL] [Abstract][Full Text] [Related]
32. The molecular basis of mTORC1-regulated translation.
Thoreen CC
Biochem Soc Trans; 2017 Feb; 45(1):213-221. PubMed ID: 28202675
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways.
Zhang J; Jia L; Lin W; Yip YL; Lo KW; Lau VMY; Zhu D; Tsang CM; Zhou Y; Deng W; Lung HL; Lung ML; Cheung LM; Tsao SW
J Virol; 2017 Mar; 91(6):. PubMed ID: 28053105
[TBL] [Abstract][Full Text] [Related]
34. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis.
Liu P; Ge M; Hu J; Li X; Che L; Sun K; Cheng L; Huang Y; Pilo MG; Cigliano A; Pes GM; Pascale RM; Brozzetti S; Vidili G; Porcu A; Cossu A; Palmieri G; Sini MC; Ribback S; Dombrowski F; Tao J; Calvisi DF; Chen L; Chen X
Hepatology; 2017 Jul; 66(1):167-181. PubMed ID: 28370287
[TBL] [Abstract][Full Text] [Related]
35. mTORC1 signaling in energy balance and metabolic disease.
Catania C; Binder E; Cota D
Int J Obes (Lond); 2011 Jun; 35(6):751-61. PubMed ID: 20877289
[TBL] [Abstract][Full Text] [Related]
36. Exploiting cancer vulnerabilities: mTOR, autophagy, and homeostatic imbalance.
Johnson CE; Tee AR
Essays Biochem; 2017 Dec; 61(6):699-710. PubMed ID: 29233879
[TBL] [Abstract][Full Text] [Related]
37. CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo Characterization.
Mortensen DS; Fultz KE; Xu S; Xu W; Packard G; Khambatta G; Gamez JC; Leisten J; Zhao J; Apuy J; Ghoreishi K; Hickman M; Narla RK; Bissonette R; Richardson S; Peng SX; Perrin-Ninkovic S; Tran T; Shi T; Yang WQ; Tong Z; Cathers BE; Moghaddam MF; Canan SS; Worland P; Sankar S; Raymon HK
Mol Cancer Ther; 2015 Jun; 14(6):1295-305. PubMed ID: 25855786
[TBL] [Abstract][Full Text] [Related]
38. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility.
Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909
[TBL] [Abstract][Full Text] [Related]
39. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
[TBL] [Abstract][Full Text] [Related]
40. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.
Balgi AD; Fonseca BD; Donohue E; Tsang TC; Lajoie P; Proud CG; Nabi IR; Roberge M
PLoS One; 2009 Sep; 4(9):e7124. PubMed ID: 19771169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
